Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Operating Leases: 2019-2021

Historic Operating Leases for Avadel Pharmaceuticals (AVDL) over the last 3 years, with Dec 2021 value amounting to $1.7 million.

  • Avadel Pharmaceuticals' Operating Leases fell 29.73% to $1.0 million in Q3 2022 from the same period last year, while for Sep 2022 it was $1.0 million, marking a year-over-year decrease of 29.73%. This contributed to the annual value of $1.7 million for FY2021, which is 7.23% down from last year.
  • Latest data reveals that Avadel Pharmaceuticals reported Operating Leases of $1.7 million as of FY2021, which was down 7.23% from $1.8 million recorded in FY2020.
  • In the past 5 years, Avadel Pharmaceuticals' Operating Leases ranged from a high of $2.3 million in FY2019 and a low of $1.7 million during FY2021.
  • Its 3-year average for Operating Leases is $2.0 million, with a median of $1.8 million in 2020.
  • Data for Avadel Pharmaceuticals' Operating Leases shows a maximum YoY fell of 20.66% (in 2020) over the last 5 years.
  • Yearly analysis of 3 years shows Avadel Pharmaceuticals' Operating Leases stood at $2.3 million in 2019, then declined by 20.66% to $1.8 million in 2020, then dropped by 7.23% to $1.7 million in 2021.